Dog Hip Dysplasia: Prevention, Pain Management, and Quality of Life

Canine hip dysplasia (CHD) is one of the most common skeletal conditions in dogs, causing chronic pain and mobility impairment. Breeding reform and early management are central to reducing its prevalence.

Key Facts

CHD affects approximately 15-20% of large and giant breed dogs globally; some breeds have rates exceeding 50%
The condition involves abnormal development of the hip joint, leading to joint laxity, arthritis, and pain
Genetics account for 25-45% of CHD heritability; environmental factors including overfeeding and over-exercise in puppies also contribute
Hip scoring schemes (BVA/KC in the UK, OFA in the USA) allow breeders to select against the condition
Signs include reluctance to exercise, difficulty rising, hind limb lameness, and bunny-hopping gait
Treatment options range from physiotherapy and weight management to total hip replacement surgery

Welfare Considerations

CHD represents a significant and largely preventable welfare burden. Dogs with severe dysplasia experience chronic pain that affects sleep, mobility, and quality of life. Pain management using NSAIDs, joint supplements, physiotherapy, hydrotherapy, and surgical intervention when appropriate can substantially improve welfare outcomes. Prevention requires commitment from breeders to use hip-scored parents and from owners to maintain appropriate body weight and avoid high-impact exercise during skeletal development. Breed registries that make hip scores public and incentivise selection against CHD can accelerate population-level improvement in affected breeds.

What You Can Do

Only purchase dogs from breeders who hip-score parent animals and share results openly
Maintain dogs at healthy weight throughout life to reduce joint loading and pain
Seek veterinary assessment and multimodal pain management for affected dogs
Support breed clubs that mandate hip scoring before registration of breeding animals